Difficulty: Medium
Average Score: 82%
Practice
Why did the patient's wife's husband not receive clot-busting medication (tPA)?
Correct answer
D
Rationale
The correct answer is D) The medication you are talking about dissolves clots and could cause more bleeding in your husband's brain.
This is the correct answer because tissue plasminogen activator (tPA) is a clot-busting medication used to treat strokes caused by blood clots. However, it is crucial to determine the type of stroke before administering tPA because if the stroke is caused by a hemorrhage (bleeding in the brain), giving tPA could worsen the condition by causing more bleeding.
Option A is incorrect because it only mentions the timeframe for therapy and does not address the specific concern about the risk of bleeding in the brain.
Option B is incorrect because it focuses on surgery as a factor for eligibility for tPA, which is not directly related to the specific situation of the patient's husband.
Option C is incorrect because it does not provide a clear explanation of why tPA was not administered to the patient's husband and redirects the discussion to the doctor without addressing the potential risks of the medication.
In an educational context, it is important for healthcare providers to understand the criteria and contraindications for administering clot-busting medications like tPA to ensure patient safety and optimal outcomes. Recognizing the type of stroke and assessing the risks and benefits of treatment options are critical skills in managing patients with neurological conditions.
This is the correct answer because tissue plasminogen activator (tPA) is a clot-busting medication used to treat strokes caused by blood clots. However, it is crucial to determine the type of stroke before administering tPA because if the stroke is caused by a hemorrhage (bleeding in the brain), giving tPA could worsen the condition by causing more bleeding.
Option A is incorrect because it only mentions the timeframe for therapy and does not address the specific concern about the risk of bleeding in the brain.
Option B is incorrect because it focuses on surgery as a factor for eligibility for tPA, which is not directly related to the specific situation of the patient's husband.
Option C is incorrect because it does not provide a clear explanation of why tPA was not administered to the patient's husband and redirects the discussion to the doctor without addressing the potential risks of the medication.
In an educational context, it is important for healthcare providers to understand the criteria and contraindications for administering clot-busting medications like tPA to ensure patient safety and optimal outcomes. Recognizing the type of stroke and assessing the risks and benefits of treatment options are critical skills in managing patients with neurological conditions.